RecruitingNCT01605266
INSIGHT (Insight Into Nephrotic Syndrome)
INSIGHT (Insight Into Nephrotic Syndrome: Investigating Genes, Health and Therapeutics)
Sponsor
The Hospital for Sick Children
Enrollment
1,000 participants
Start Date
Jan 1, 2011
Study Type
OBSERVATIONAL
Conditions
Summary
INSIGHT is a longitudinal study of childhood nephrotic syndrome to determine genetic, serologic and environmental factors contributing to nephrotic syndrome and disease progression.
Eligibility
Min Age: 6 MonthsMax Age: 18 Years
Inclusion Criteria4
- diagnosis of nephrotic syndrome
- signed informed consent and assent appropriate for age
- ages 6 months -18 years old and
- ability to complete questionnaires
Exclusion Criteria4
- congenital nephrotic syndrome (less than age 1)
- syndromic disease with multiple organ involvement
- inability to provide consent by primary care providers
- conditions such as systemic lupus erythematous.
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(4)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT01605266
Related Trials
Immune System Related Kidney Disease
NCT000019791 location
A Smart Phone Application to Improve Adoption of the 2024 Kidney Disease Improving Global Outcomes (KDIGO) Chronic Kidney Disease (CKD) Guidelines
NCT075619572 locations
Rituximab Plus Cyclosporine in Idiopathic Membranous Nephropathy
NCT009779772 locations
Multitarget Strategy for Primary Podocytopathies
NCT067188942 locations
Belimumab With Rituximab for Primary Membranous Nephropathy
NCT0394985520 locations